GENEVA, March 30 -- CRUCIBLE THERAPEUTICS LTD (The Innovation Centre, 217 PortobelloSheffield S1 4DP) filed a patent application (PCT/GB2025/052059) for "SRSF1 ANTAGONIST" on Sep 19, 2025. With publication no. WO/2026/062390, the details related to the patent application was published on Mar 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FOLEY, Jonathan (Crucible Therapeutics Ltd, The Innovation Centre, 217 PortobelloSheffield S1 4DP), HAUTBERGUE, Guillaume Marcel Pierre (Crucible Therapeutics Ltd, The Innovation Centre, 217 PortobelloSheffield S1 4DP)
Abstract: This disclosure relates...